Submit Content
Sponsored in Part By
Sponsored
Lung Cancer - Multimodality Therapy
Thoracic
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer
By Marco Nardini
Mar. 4, 2019
0
Thoracic
Aggressive Radiotherapy, Surgery Doubles Overall Survival in Non-Small Cell Lung Cancer With Limited Mets
By Mark Ferguson
Oct. 23, 2018
0
Thoracic
Overall Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC
By Mark Ferguson
Sep. 25, 2018
0
Thoracic
PACIFIC: Time for a Surgical IIIA Uprising
By Mark Ferguson
Aug. 20, 2018
0
Cancer
Making Difficult Decisions in Lung Cancer: Oligometastasis, Ground Glass Opacities, Bilateral Lung Lesions, Surgery for Recurrence
By Gilbert Massard
Jul. 5, 2018
0
Thoracic
Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base
By Mark Ferguson
Apr. 13, 2018
0
Thoracic
Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
By Mark Ferguson
Feb. 5, 2018
1
Thoracic
Lung Cancer Awareness Month—A Lot of Progress, But More Work Needs to Be Done
By Mark Ferguson
Oct. 24, 2017
0
Thoracic
Scientific Advances in Thoracic Oncology 2016
By Mark Ferguson
Aug. 2, 2017
0
Thoracic
Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer
By Mark Ferguson
Aug. 28, 2016
0
Thoracic
Adjuvant Chemotherapy for T3 Non-Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe
By Lisa Brown
Jul. 15, 2016
0
Thoracic
Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?
By Mark Ferguson
Nov. 16, 2015
0
1 2 3

Log In

New to CTSNet? Sign Up

Forgot Password